Response to chemokine

pathway activity — cross-omics
GO:1990868Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to chemokine pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SLA2, FASLG, and CD48, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to chemokine activity versus SLA2 in BRCA (Pearson r = 0.36).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCASLA2 →+0.741+0.349.005.00438
CCRCCFASLG →+0.652+0.467<.001.00338
UCECCD48 →+0.691+0.378.006.00337
LSCCTBX21 →+0.613+0.461<.001.00237
CCRCCCRTAM →+0.694+0.640<.001<.00137
CCRCCSCIMP →+0.350+0.427<.001.00737
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1990868 vs SLA2 — BRCA

Per-sample scatter of Response to chemokine activity vs SLA2 in BRCA.

Explore this scatter interactively →

Exploration